Accounting News
PR Newswire: PR Newswire:
-
(IMMU) Alert: Johnson Fistel Investigates Proposed Sale of Immunomedics; Is $88 a Fair Price?
on September 21, 2020 at 1:45 am
SAN DIEGO, Sept. 20, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Immunomedics Inc. (NASDAQ: IMMU) ("Immunomedics" or the "Company") breached their fiduciary duties in connection with the proposed sale...
-
Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain
on September 21, 2020 at 1:30 am
SHANGHAI, Sept. 20, 2020 /PRNewswire/ -- Shanghai SIMR Biotechnology Co., Ltd. (hereinafter referred to as "SIMR" or "Company") announced that, the clinical trial in patients with peripheral neuropathic pain has been initiated for the candidate drug SR419, and the first patient has been...
-
Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities
on September 21, 2020 at 1:22 am
SHANGHAI, Sept. 20, 2020 /PRNewswire/ -- Viva Biotech (Shanghai) Co., Ltd. (hereinafter referred to as "Viva Biotech" or "The Company") entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 100% of the equity...
-
Vieworks Renews VL Series, High-performance and Cost-effective Line Scan Cameras
on September 21, 2020 at 1:00 am
ANYANG, South Korea, Sept. 20, 2020 /PRNewswire/ -- Vieworks' VL Series, first launched in 2014, has been reintroduced to the machine vision industry with more powerful features but still at an affordable price. VL-8K and VL-16K, the two models in VL Series, deliver maximum line rates of...
-
Dr. Paul Kaminski joins Immersive Wisdom's Federal Advisory Board
on September 21, 2020 at 1:00 am
BOCA RATON, Fla., Sept. 20, 2020 /PRNewswire/ -- Immersive Wisdom, Inc., provider of a game-changing real-time geospatial collaboration platform for Joint-All Domain Command & Control, Mission Planning, Targeting, and Mission Command, announced that Dr. Paul Kaminski, renowned...
-
KPS Capital Partners Agrees To Acquire Substantially All Of The Assets Of Garrett Motion Inc.
on September 21, 2020 at 12:09 am
KPS TO PARTICIPATE IN COMPANY'S DIP FINANCING TO SUPPORT OPERATIONS KPS HAS OBTAINED COMMITTED EXIT FINANCING NEW YORK, Sept. 20, 2020 /PRNewswire/ -- KPS Capital Partners, LP ("KPS") announced today that, through a newly formed affiliate, it has entered into a stock and asset purchase...
-
Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
on September 21, 2020 at 12:00 am
SAN FRANCISCO and SUZHOU, China, Sept. 20, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other...
-
Innovent and Lilly Release Biomarker Results of TYVYT® (Sintilimab Injection) in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
on September 21, 2020 at 12:00 am
SAN FRANCISCO and SUZHOU, China, Sept. 20, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other...
-
Openspace Ventures Welcomes New Team Members and Announces First Investment from OSV+
on September 21, 2020 at 12:00 am
SINGAPORE, Sept. 20, 2020 /PRNewswire/ -- Openspace Ventures, focused on investing in technology opportunities in Southeast Asia since 2014, is pleased to welcome new senior members to its team as it expands its platform during a dynamic phase of ongoing development for the region....
-
MPTF Hosts "The Evening Before: Special Edition"
on September 20, 2020 at 11:21 pm
WOODLAND HILLS, Calif., Sept. 20, 2020 /PRNewswire/ -- September 20, 2020 – Last night, MPTF (Motion Picture & Television Fund) hosted the 14th annual edition of its iconic pre-Emmy Awards party, reimagined as "The Evening Before: Special Edition." The virtual benefit took place on...
PR Newswire: PR Newswire:
-
Shanghai Electric présente des solutions énergétiques intelligentes à l'Exposition Industrielle Internationale Chinoise lors de la Journée Monde Propre
on September 20, 2020 at 8:17 pm
Shanghai a présenté des exemples de Villes Intelligentes, d'Énergies Intelligentes, de Fabrication Intelligente et de Transports Intelligents. SHANGHAI, le 20 septembre 2020 /PRNewswire/ -- Shanghai Electric a fait forte impression à l'Exposition Industrielle Internationale Chinoise (le «...
-
Shanghai Electric presenta soluciones en energía inteligente durante la Exposición Industrial Internacional de China en el Día Mundial de la Limpieza
on September 20, 2020 at 8:14 pm
Shanghai Electric presentó exhibiciones sobre Ciudad inteligente, Energía inteligente, Manufactura inteligente y Transporte inteligente SHANGHÁI, 20 de septiembre de 2020 /PRNewswire/ -- Shanghai Electric causó gran impresión en la 22a Exposición Industrial Internacional de China (la...
-
A Shanghai Electric apresenta a Smart Energy Solution no World´s Clean Up Day (Dia da Limpeza Mundial) na China International Industrial Expo
on September 20, 2020 at 8:11 pm
A Shanghai Electric fez na exposição apresentações sobre Cidade inteligente, Energia inteligente, Fabricação inteligente e Transporte inteligente SHANGHAI, 20 de setembro de 2020 /PRNewswire/ -- A Shanghai Electric provocou uma forte impressão na 22ª Expo Industrial Internacional da China...
-
Shanghai Electric präsentiert Smart Energy Solution auf der China International Industrial Expo am World's Clean Up Day
on September 20, 2020 at 8:08 pm
Shanghai Electric präsentierte auf der Expo Ausstellungen zu Smart City, Smart Energy, Intelligent Manufacturing und Intelligent Transportation SHANGHAI, 20. September 2020 /PRNewswire/ -- Shanghai Electric hat auf der 22. China International Industrial Expo (die „Shanghai Industrial...
-
Statement from PepsiCo Chairman and CEO Ramon L. Laguarta on Passing of Donald M. Kendall
on September 20, 2020 at 6:50 pm
PURCHASE, N.Y., Sept. 20, 2020 /PRNewswire/ -- "All of us at PepsiCo are devastated by the passing of Don Kendall. Don was the architect of the PepsiCo family. He was relentless about growing our business, a fearless leader, and the ultimate salesman. He believed in business as a way to...
-
Statement by the Family of Donald M. Kendall
on September 20, 2020 at 6:39 pm
PURCHASE, N.Y., Sept. 20, 2020 /PRNewswire/ -- "Donald M. Kendall passed away peacefully last night, September 19. He was 99 years old and died of natural causes, at home with his wife of 55 years and surrounded by the large and thriving family he shepherded. Our family is heartbroken,...
-
Verzenio® Significantly Reduced the Risk of Cancer Recurrence by 25% for People with HR+, HER2- High Risk Early Breast Cancer
on September 20, 2020 at 6:01 pm
INDIANAPOLIS, Sept. 20, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Verzenio® (abemaciclib) in combination with standard adjuvant endocrine therapy (ET) significantly decreased the risk of breast cancer recurrence by 25 percent compared to standard adjuvant ET...
-
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - ONDK, MR, SBPH, JCAP
on September 20, 2020 at 4:30 pm
NEW YORK, Sept. 20, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating: On Deck Capital, Inc. (NYSE: ONDK) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Enova...
-
Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine
on September 20, 2020 at 12:39 pm
THOUSAND OAKS, Calif., Sept. 20, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that updated data from the full Phase 1 cohort of the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510) in 129 patients across multiple advanced solid tumors, were...
-
Blueprint Medicines Reports ARROW Trial Data at ESMO Virtual Congress 2020 Demonstrating Durable Clinical Benefits of GAVRETO™ (Pralsetinib) in Patients with Advanced RET-Mutant Medullary Thyroid Cancer
on September 20, 2020 at 12:25 pm
CAMBRIDGE, Mass., Sept. 20, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced results from the ongoing ARROW clinical trial showing durable...
PR Newswire: PR Newswire:
-
(IMMU) Alert: Johnson Fistel Investigates Proposed Sale of Immunomedics; Is $88 a Fair Price?
on September 21, 2020 at 1:45 am
SAN DIEGO, Sept. 20, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Immunomedics Inc. (NASDAQ: IMMU) ("Immunomedics" or the "Company") breached their fiduciary duties in connection with the proposed sale...
-
Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain
on September 21, 2020 at 1:30 am
SHANGHAI, Sept. 20, 2020 /PRNewswire/ -- Shanghai SIMR Biotechnology Co., Ltd. (hereinafter referred to as "SIMR" or "Company") announced that, the clinical trial in patients with peripheral neuropathic pain has been initiated for the candidate drug SR419, and the first patient has been...
-
Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities
on September 21, 2020 at 1:22 am
SHANGHAI, Sept. 20, 2020 /PRNewswire/ -- Viva Biotech (Shanghai) Co., Ltd. (hereinafter referred to as "Viva Biotech" or "The Company") entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 100% of the equity...
-
Vieworks Renews VL Series, High-performance and Cost-effective Line Scan Cameras
on September 21, 2020 at 1:00 am
ANYANG, South Korea, Sept. 20, 2020 /PRNewswire/ -- Vieworks' VL Series, first launched in 2014, has been reintroduced to the machine vision industry with more powerful features but still at an affordable price. VL-8K and VL-16K, the two models in VL Series, deliver maximum line rates of...
-
Dr. Paul Kaminski joins Immersive Wisdom's Federal Advisory Board
on September 21, 2020 at 1:00 am
BOCA RATON, Fla., Sept. 20, 2020 /PRNewswire/ -- Immersive Wisdom, Inc., provider of a game-changing real-time geospatial collaboration platform for Joint-All Domain Command & Control, Mission Planning, Targeting, and Mission Command, announced that Dr. Paul Kaminski, renowned...
-
KPS Capital Partners Agrees To Acquire Substantially All Of The Assets Of Garrett Motion Inc.
on September 21, 2020 at 12:09 am
KPS TO PARTICIPATE IN COMPANY'S DIP FINANCING TO SUPPORT OPERATIONS KPS HAS OBTAINED COMMITTED EXIT FINANCING NEW YORK, Sept. 20, 2020 /PRNewswire/ -- KPS Capital Partners, LP ("KPS") announced today that, through a newly formed affiliate, it has entered into a stock and asset purchase...
-
Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
on September 21, 2020 at 12:00 am
SAN FRANCISCO and SUZHOU, China, Sept. 20, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other...
-
Innovent and Lilly Release Biomarker Results of TYVYT® (Sintilimab Injection) in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
on September 21, 2020 at 12:00 am
SAN FRANCISCO and SUZHOU, China, Sept. 20, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other...
-
Openspace Ventures Welcomes New Team Members and Announces First Investment from OSV+
on September 21, 2020 at 12:00 am
SINGAPORE, Sept. 20, 2020 /PRNewswire/ -- Openspace Ventures, focused on investing in technology opportunities in Southeast Asia since 2014, is pleased to welcome new senior members to its team as it expands its platform during a dynamic phase of ongoing development for the region....
-
MPTF Hosts "The Evening Before: Special Edition"
on September 20, 2020 at 11:21 pm
WOODLAND HILLS, Calif., Sept. 20, 2020 /PRNewswire/ -- September 20, 2020 – Last night, MPTF (Motion Picture & Television Fund) hosted the 14th annual edition of its iconic pre-Emmy Awards party, reimagined as "The Evening Before: Special Edition." The virtual benefit took place on...
PR Newswire: PR Newswire:
-
(IMMU) Alert: Johnson Fistel Investigates Proposed Sale of Immunomedics; Is $88 a Fair Price?
on September 21, 2020 at 1:45 am
SAN DIEGO, Sept. 20, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Immunomedics Inc. (NASDAQ: IMMU) ("Immunomedics" or the "Company") breached their fiduciary duties in connection with the proposed sale...
-
Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain
on September 21, 2020 at 1:30 am
SHANGHAI, Sept. 20, 2020 /PRNewswire/ -- Shanghai SIMR Biotechnology Co., Ltd. (hereinafter referred to as "SIMR" or "Company") announced that, the clinical trial in patients with peripheral neuropathic pain has been initiated for the candidate drug SR419, and the first patient has been...
-
Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities
on September 21, 2020 at 1:22 am
SHANGHAI, Sept. 20, 2020 /PRNewswire/ -- Viva Biotech (Shanghai) Co., Ltd. (hereinafter referred to as "Viva Biotech" or "The Company") entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 100% of the equity...
-
Vieworks Renews VL Series, High-performance and Cost-effective Line Scan Cameras
on September 21, 2020 at 1:00 am
ANYANG, South Korea, Sept. 20, 2020 /PRNewswire/ -- Vieworks' VL Series, first launched in 2014, has been reintroduced to the machine vision industry with more powerful features but still at an affordable price. VL-8K and VL-16K, the two models in VL Series, deliver maximum line rates of...
-
Dr. Paul Kaminski joins Immersive Wisdom's Federal Advisory Board
on September 21, 2020 at 1:00 am
BOCA RATON, Fla., Sept. 20, 2020 /PRNewswire/ -- Immersive Wisdom, Inc., provider of a game-changing real-time geospatial collaboration platform for Joint-All Domain Command & Control, Mission Planning, Targeting, and Mission Command, announced that Dr. Paul Kaminski, renowned...
-
KPS Capital Partners Agrees To Acquire Substantially All Of The Assets Of Garrett Motion Inc.
on September 21, 2020 at 12:09 am
KPS TO PARTICIPATE IN COMPANY'S DIP FINANCING TO SUPPORT OPERATIONS KPS HAS OBTAINED COMMITTED EXIT FINANCING NEW YORK, Sept. 20, 2020 /PRNewswire/ -- KPS Capital Partners, LP ("KPS") announced today that, through a newly formed affiliate, it has entered into a stock and asset purchase...
-
Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
on September 21, 2020 at 12:00 am
SAN FRANCISCO and SUZHOU, China, Sept. 20, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other...
-
Innovent and Lilly Release Biomarker Results of TYVYT® (Sintilimab Injection) in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
on September 21, 2020 at 12:00 am
SAN FRANCISCO and SUZHOU, China, Sept. 20, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other...
-
Openspace Ventures Welcomes New Team Members and Announces First Investment from OSV+
on September 21, 2020 at 12:00 am
SINGAPORE, Sept. 20, 2020 /PRNewswire/ -- Openspace Ventures, focused on investing in technology opportunities in Southeast Asia since 2014, is pleased to welcome new senior members to its team as it expands its platform during a dynamic phase of ongoing development for the region....
-
MPTF Hosts "The Evening Before: Special Edition"
on September 20, 2020 at 11:21 pm
WOODLAND HILLS, Calif., Sept. 20, 2020 /PRNewswire/ -- September 20, 2020 – Last night, MPTF (Motion Picture & Television Fund) hosted the 14th annual edition of its iconic pre-Emmy Awards party, reimagined as "The Evening Before: Special Edition." The virtual benefit took place on...